IDI announces availability of 1H 2026 interim financial report (as of June 30, 2026)
Bitget2026/09/30 10:23- IDI published its half-year financial report for the six months ended June 30, 2026.
- Report posted at https://cee0c8e13845.e9e0188a.ca-central-1.token.awswaf.com/sites/default/files/company_press_releases/attachments/2026/09/30/cpr03_lesechos_16165_1437153_CP_mise__disposition_du_rapport_financier_semestriel.pdf?VersionId=ZGIQPfinKhIbZYQKuLIJoU0YN.3JoXOj.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Ido Ben-Natan: Frequent on-chain security incidents, AI agents will increase risks
BTC rebounds and breaks through 83,000 USDT, with a 24-hour decrease of 1%
Why did the Reserve Bank of Australia raise interest rates two weeks ago? Meeting minutes reveal inflation risks have become a reality, and waiting would be too costly
The Reserve Bank of Australia acknowledges that the trade-off between inflation and full employment has worsened, but maintains that its goal is to return the Consumer Price Index (CPI) to the 2-3% target range.
Three-year remission rate up to 94%! Johnson & Johnson (JNJ.US) Tremfya Crohn's disease study shows positive long-term results
Long-term data from two Phase 3 clinical trials by Johnson & Johnson show that adult Crohn's disease patients treated with Tremfya (guselkumab) achieved a clinical remission rate of up to 94% over three years.
Crypto prices
More
